Amyris’s trans-β-Farnesene is produced through fermentation of sugars by yeast. Target genes are selected to change the yeast’s metabolism, converting the yeast from an ethanol-producing organism into a hydro-carbon producing organism.

Amyris’s platform enables the production of selected molecules at high purity levels. It also provides three distinct advantages over the existing sources: first, it efficiently produces compounds that can’t be made by chemical synthesis;

second, it replaces compounds typically derived from plant sources that can’t be extracted reliably; and third, it replaces compounds made from petrochemicals, with renewable compounds.

This technology platform is revolutionary in allowing commercially viable levels of production of the trans-β-Farnesene molecule.